CAMP logo

CAMP4 Therapeutics (CAMP)

Profile

Full Name

CAMP4 Therapeutics

Ticker Symbol

CAMP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 11, 2024

Indexes

Not included

Website

http://www.camp4tx.com

Employees

55

Key Details

Price

$1.85(+3.93%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$652.00K(+86.29% YoY)

Annual EPS

-$11.04(-171.57% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.85
CAMP price is $1.85

30-Day Relative Volume

5.22
CAMP 30-day relative volume is 5.22

Price Performance

Price Most recent change

+3.93%
CAMP price was up +3.93% on Apr 15, 2025

Price YTD change

-64.56%
CAMP price is down -64.56% since January 1st

Price 1-year change

-
CAMP price 1-year change is unknown

Price 3-year change

-
CAMP price 3-year change is unknown

Price Range

Price All-time high

$12.30
CAMP price is currently -84.96% below its historical high of $12.30

Price 3-year low

$1.76
CAMP price is currently +5.11% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$37.30M
CAMP market capitalization is $37.30 million

Market cap 3-year change

-
CAMP market capitalization 3-year change is unknown

Market cap All-time high

$228.99M
CAMP market capitalization is currently -83.71% below its historical high of $228.99 million

Market cap sector rank

33.88%
CAMP market capitalization is higher than 33.88% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1121.29%
CAMP shares outstanding is up +1121.29% year-on-year

Shares Outstanding 3-Year Change

+1186.19%
CAMP shares outstanding is up +1186.19% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.04
CAMP beta is 1.04

200-day SMA

$6.13
CAMP price is currently -69.83% below its 200-day simple moving average

50-day SMA

$4.34
CAMP price is currently -57.36% below its 50-day simple moving average

RSI

22.85
CAMP 14-day relative strength index is 22.85

Volume

5.22
CAMP 30-day relative volume is 5.22

ATR

$0.48
CAMP average true range is $0.48

10-day Historical Volatility

90.54%
CAMP 10-day historical volatility is 90.54%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$652.00K
CAMP annual revenue is $652.00 thousand

Revenue Analysts estimate

$240.00M
CAMP annual revenue is currently -99.73% lower than the consensus analysts' forecast

Revenue 1-year change

+86.29%
CAMP annual revenue is up +86.29% year-on-year

Revenue Sector rank

11.17%
CAMP annual revenue is higher than 11.17% of companies in Healthcare sector

EPS

EPS

-$11.04
CAMP annual earnings per share is -$11.04

EPS Analysts estimate

$1.61
CAMP annual earnings per share is currently -785.71% lower than the consensus analysts' forecast

EPS 1-year change

-171.57%
CAMP annual earnings per share is down -171.57% year-on-year

EPS Sector rank

11.1%
CAMP annual earnings per share is higher than 11.1% of companies in Healthcare sector

Profit

Gross profit

-
CAMP annual gross profit value is unknown

Gross margin

-
CAMP annual gross profit margin value is unknown

Operating profit

-$53.09M
CAMP annual operating income is -$53.09 million

Operating margin

-8142.33%
CAMP annual operating profit margin is -8142.33%

Net income

-$51.79M
CAMP annual net profit is -$51.79 million

Net margin

-7943.40%
CAMP annual net profit margin is -7943.40%

Expenses

Total expenses

$53.74M
CAMP annual total expenses is $53.74 million

Operating expenses

$53.74M
CAMP annual total operating expenses is $53.74 million

Cost of goods sold

-
CAMP annual cost of goods sold value is unknown

Selling, general & administrative expenses

$14.92M
CAMP annual SGA is $14.92 million

Depreciation and amortization

$1.70M
CAMP annual depreciation & amortization is $1.70 million

Interest expense

-
CAMP annual interest expense value is unknown

Income tax

-
CAMP annual income tax value is unknown

EBIT & EBITDA

EBIT

-$53.09M
CAMP annual earnings before interest & taxes is -$53.09 million

EBITDA

-$51.39M
CAMP annual EBITDA is -$51.39 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$78.31M
CAMP annual total assets is $78.31 million

Non current assets

$11.92M
CAMP annual long term assets is $11.92 million

Current assets

$66.38M
CAMP annual total current assets is $66.38 million

Cash and cash equivalents

$64.04M
CAMP annual cash & cash equivalents is $64.04 million

Accounts receivable

-
CAMP annual accounts receivable value is unknown

Inventory

-
CAMP annual inventory value is unknown

Liabilities

Total liabilities

$15.16M
CAMP annual total liabilities is $15.16 million

Long term liabilities

$5.57M
CAMP annual total long term liabilities is $5.57 million

Current liabilities

$9.60M
CAMP annual total current liabilities is $9.60 million

Accounts payable

$1.21M
CAMP annual accounts payable is $1.21 million

Debt

Total debt

$8.65M
CAMP annual total debt is $8.65 million

Total debt 1-year change

-26.04%
CAMP annual total debt is down -26.04% year-on-year

Long term debt

$5.56M
CAMP annual long term debt is $5.56 million

Short term debt

$3.08M
CAMP annual short term debt is $3.08 million

Equity & Capital

Shareholders equity

$63.14M
CAMP annual stockholders equity is $63.14 million

Book value

$63.14M
CAMP annual book value is $63.14 million

Retained earnings

-$211.75M
CAMP annual retained earnings is -$211.75 million

Working capital

$56.78M
CAMP annual working capital is $56.78 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$45.56M
CAMP annual cash flow from operations is -$45.56 million

Cash from operations 1-year change

-3.19%
CAMP annual cash flow from operations is down -3.19% year-on-year

Cash from investing

-$441.00K
CAMP annual cash flow from investing activities is -$441.00 thousand

Cash from investing 1-year change

+34.96%
CAMP annual cash flow from investing activities is up +34.96% year-on-year

Cash from financing

$71.66M
CAMP annual cash flow from financing activities is $71.66 million

Cash from financing 1-year change

+23707.97%
CAMP annual cash flow from financing activities is up +23707.97% year-on-year

CAPEX

CAPEX

$441.00K
CAMP annual capital expenditures is $441.00 thousand

CAPEX 1-year change

-34.96%
CAMP annual capital expenditures is down -34.96% year-on-year

Free Cash Flow

Free cash flow

-$46.00M
CAMP annual free cash flow is -$46.00 million

Free cash flow 1-year change

-2.61%
CAMP annual free cash flow is down -2.61% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CAMP annual gross profit margin value is unknown

Operating margin

-8142.33%
CAMP annual operating profit margin is -8142.33%

Net margin

-7943.40%
CAMP annual net profit margin is -7943.40%

ROA & ROE

ROA

-77.73%
CAMP annual return on assets is -77.73%

ROE

-82.02%
CAMP annual return on equity is -82.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CAMP price to earnings ratio value is unknown

PE ratio Sector rank

-
CAMP price to earnings ratio is unknown

PB Ratio

PB ratio

0.59
CAMP price to book ratio is 0.59

PB ratio Sector rank

32.43%
CAMP price to book ratio is higher than 32.43% of companies in Healthcare sector

PS Ratio

PS ratio

57.21
CAMP price to sales ratio is 57.21

PS ratio Sector rank

92.95%
CAMP price to sales ratio is higher than 92.95% of companies in Healthcare sector

Enterprise value

Enterprise value

-$18.09M
CAMP enterprise value is -$18.09 million

Enterprise value Sector rank

3.39%
CAMP enterprise value is higher than 3.39% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.68
CAMP EV/EBITDA is 0.68

EV/EBITDA Sector rank

73.63%
CAMP EV/EBITDA is higher than 73.63% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.92
CAMP annual current ratio is 6.92

Quick ratio

-
CAMP annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CAMP annual debt to equity ratio is 0.00

Interest coverage ratio

-
CAMP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CAMP piotroski f-score value is unknown

Altman Z-Score

-3.67
CAMP altman z-score is -3.67

Analyst ratings

Recent major analysts updates

Nov 5, 24 William Blair
Outperform
Nov 5, 24 Piper Sandler
Overweight
Nov 5, 24 Leerink Partners
Outperform
Nov 5, 24 JP Morgan
Overweight
Jan 11, 24 Goldman Sachs
Sell
Oct 9, 23 Goldman Sachs
Sell
Oct 6, 23 Roth MKM
Buy
Oct 6, 23 Craig-Hallum
Hold
Aug 29, 23 Roth MKM
Buy
Jul 13, 23 Goldman Sachs
Sell

Institutional Ownership

Similar stocks

DYAI logo
Dyadic International (DYAI)
DXR logo
Daxor (DXR)
XLO logo
Xilio Therapeutics (XLO)
Opus Genetics (IRD)
Rein Therapeutics (RNTX)
ANTX logo
AN2 Therapeutics (ANTX)
LTRN logo
Lantern Pharma (LTRN)
OKYO logo
OKYO Pharma Limited (OKYO)
APLT logo
Applied Therapeutics (APLT)
  • What is the ticker symbol for CAMP4 Therapeutics?
  • Does CAMP4 Therapeutics pay dividends?
  • What sector is CAMP4 Therapeutics in?
  • What industry is CAMP4 Therapeutics in?
  • What country is CAMP4 Therapeutics based in?
  • When did CAMP4 Therapeutics go public?
  • Is CAMP4 Therapeutics in the S&P 500?
  • Is CAMP4 Therapeutics in the NASDAQ 100?
  • Is CAMP4 Therapeutics in the Dow Jones?
  • When was CAMP4 Therapeutics's last earnings report?
  • When does CAMP4 Therapeutics report earnings?
  • Should I buy CAMP4 Therapeutics stock now?

What is the ticker symbol for CAMP4 Therapeutics?

The ticker symbol for CAMP4 Therapeutics is NASDAQ:CAMP

Does CAMP4 Therapeutics pay dividends?

No, CAMP4 Therapeutics does not pay dividends

What sector is CAMP4 Therapeutics in?

CAMP4 Therapeutics is in the Healthcare sector

What industry is CAMP4 Therapeutics in?

CAMP4 Therapeutics is in the Biotechnology industry

What country is CAMP4 Therapeutics based in?

CAMP4 Therapeutics is headquartered in United States

When did CAMP4 Therapeutics go public?

CAMP4 Therapeutics's initial public offering (IPO) was on October 11, 2024

Is CAMP4 Therapeutics in the S&P 500?

No, CAMP4 Therapeutics is not included in the S&P 500 index

Is CAMP4 Therapeutics in the NASDAQ 100?

No, CAMP4 Therapeutics is not included in the NASDAQ 100 index

Is CAMP4 Therapeutics in the Dow Jones?

No, CAMP4 Therapeutics is not included in the Dow Jones index

When was CAMP4 Therapeutics's last earnings report?

CAMP4 Therapeutics's most recent earnings report was on Mar 27, 2025

When does CAMP4 Therapeutics report earnings?

The next expected earnings date for CAMP4 Therapeutics is May 30, 2025

Should I buy CAMP4 Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page